Background illustration for clinical trials search

Paid Clinical Trials Stamford

Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

for
Severe Hypertriglyceridemia
Location: New York NY, Hamden CT, Pennington NJ, Worcester MA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07269210

Phase2, Recruiting

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, New Haven CT, Toronto, San Antonio TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07166601

Phase1, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: New York NY, Hackensack NJ, New Haven CT,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase1, Recruiting

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

for
Open Surgery, Lymphedema, Free Tissue Transfer, Microsurgery,
Location: New York NY, New Haven CT, Buffalo NY, Cleveland OH,
Sponsor: MMI (Medical Microinstruments, Inc.)

Sex: All

Age: 22+

Code: NCT06725030

Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07087054

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: New York NY, New Haven CT, Boston MA, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase1, Recruiting

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

for
IgA Nephropathy
Location: New York NY, New Haven CT, Clifton Park NY,
Sponsor: Calliditas Therapeutics AB

Sex: All

Age: 18+

Code: NCT06712407

Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis
Location: New York NY, Farmington CT, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals

Sex: All

Age: 40+

Code: NCT05571059

Phase2, Recruiting

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

for
T Cell Lymphoma, T-cell Lymphoma
Location: New York NY, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05996185

Phase2, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: New York NY, New Haven CT, Hartford CT, Fairfax VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

for
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma,
Location: New York NY, Hartford CT, Philadelphia PA, Baltimore MD,
Sponsor: Endospan Ltd.

Sex: All

Age: 18+

Code: NCT04471909

Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Paramus NJ, Hackensack NJ, New Haven CT,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Paramus NJ, New York NY, New Haven CT, West Reading PA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

Shield Post-Approval Study Protocol

for
Colo-rectal Cancer
Location: Valley Stream NY, Ridgewood NJ, New York NY, Clifton NJ,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 45 - 70+

Code: NCT06880055

Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: New York NY, New Haven CT, Philadelphia PA, Montreal,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase3, Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Farmington CT, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase3, Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Hackensack NJ, New Haven CT, Philadelphia PA, Boston MA,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase1, Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Oceanside NY, Bloomfield NJ, Waterford CT, Kingston PA,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Long Island City NY, New York NY, New Haven CT,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase2, Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for
Crohn Disease, Colitis, Ulcerative
Location: New York NY, Bristol CT, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase3, Recruiting